Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 194.096.683.363.892302-1.81
AnnualDec 183.984.963.343.932604-1.44
AnnualDec 174.324.564.154.322612-0.01
QuarterlySep 171.071.200.941.0721210.11
QuarterlyDec 171.181.311.021.182102-0.13
QuarterlyMar 181.031.140.871.05500-3.70
QuarterlyJun 181.071.200.951.074000.00
Long Term Growth -4.83-3.00-6.58-4.9030163.33
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 165.145.110.57
QuarterlySep 161.311.282.40
QuarterlyDec 161.381.352.52
QuarterlyMar 171.061.032.81
QuarterlyJun 171.021.06-3.53
AnnualDec 155.425.44-0.38
AnnualDec 145.075.07-0.01
P/E Ratios
PeriodP/E Ratio
FY03.34
FY13.98
FY24.32
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY0-15.94-3.410.870
FY2/FY1-7.97-9.691.019
FY3/FY22.941.931.010
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.